Literature DB >> 18597164

Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.

Jan-Willem Hofman1, Myrra G Carstens, Femke van Zeeland, Conny Helwig, Frits M Flesch, Wim E Hennink, Cornelus F van Nostrum.   

Abstract

PURPOSE: To study the in vitro photocytotoxicity and cellular uptake of biodegradable polymeric micelles loaded with the photosensitizer mTHPC, including the effect of lipase-catalyzed micelle degradation.
METHODS: Micelles of mPEG750-b-oligo(epsilon-caprolactone)5 (mPEG750-b-OCL5) with a hydroxyl (OH), benzoyl (Bz) or naphthoyl (Np) end group were formed and loaded with mTHPC by the film hydration method. The cellular uptake of the loaded micelles, and their photocytotoxicity on human neck squamous carcinoma cells in the absence and presence of lipase were compared with free and liposomal mTHPC (Fospeg).
RESULTS: Micelles composed of mPEG750-b-OCL5 with benzoyl and naphtoyl end groups had the highest loading capacity up to 30% (w/w), likely due to pi-pi interactions between the aromatic end group and the photosensitizer. MTHPC-loaded benzoylated micelles (0.5 mg/mL polymer) did not display photocytotoxicity or any mTHPC-uptake by the cells, in contrast to free and liposomal mTHPC. After dilution of the micelles below the critical aggregation concentration (CAC), or after micelle degradation by lipase, photocytotoxicity and cellular uptake of mTHPC were restored.
CONCLUSION: The high loading capacity of the micelles, the high stability of mTHPC-loaded micelles above the CAC, and the lipase-induced release of the photosensitizer makes these micelles very promising carriers for photodynamic therapy in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597164      PMCID: PMC2515570          DOI: 10.1007/s11095-008-9590-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  40 in total

1.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine.

Authors:  Jubo Liu; Yuehua Xiao; Christine Allen
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

2.  Investigation of Foscan interactions with plasma proteins.

Authors:  Siarhei Sasnouski; Vladimir Zorin; Ivan Khludeyev; Marie-Ange D'Hallewin; François Guillemin; Lina Bezdetnaya
Journal:  Biochim Biophys Acta       Date:  2005-07-06

Review 3.  Block copolymer micelles: preparation, characterization and application in drug delivery.

Authors:  Geneviève Gaucher; Marie-Hélène Dufresne; Vinayak P Sant; Ning Kang; Dusica Maysinger; Jean-Christophe Leroux
Journal:  J Control Release       Date:  2005-11-11       Impact factor: 9.776

4.  Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.

Authors:  Julia Buchholz; Barbara Kaser-Hotz; Tania Khan; Carla Rohrer Bley; Katja Melzer; Reto A Schwendener; Malgorzata Roos; Heinrich Walt
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

5.  A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(epsilon-caprolactone) micelles.

Authors:  Myrra G Carstens; Cornelus F van Nostrum; Ruud Verrijk; Leo G J de Leede; Daan J A Crommelin; Wim E Hennink
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

Review 6.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

7.  mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

Authors:  Colin Hopper; Alexander Kübler; Harry Lewis; I Bing Tan; Graham Putnam
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

8.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

Review 9.  Polymeric micelles for delivery of poorly water-soluble compounds.

Authors:  Glen S Kwon
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2003       Impact factor: 4.889

10.  Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin.

Authors:  Masayuki Yokoyama; Praneet Opanasopit; Teruo Okano; Kumi Kawano; Yoshie Maitani
Journal:  J Drug Target       Date:  2004-07       Impact factor: 5.121

View more
  10 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 2.  Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future.

Authors:  Sophie Marchal; Gilles Dolivet; Henri-Pierre Lassalle; François Guillemin; Lina Bezdetnaya
Journal:  Lasers Med Sci       Date:  2015-01-07       Impact factor: 3.161

3.  In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.

Authors:  Irati Beltrán Hernández; Timo W M De Groof; Raimond Heukers; Sabrina Oliveira
Journal:  Methods Mol Biol       Date:  2022

4.  Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.

Authors:  María García-Díaz; Masayoshi Kawakubo; Pawel Mroz; M Lluïsa Sagristà; Margarita Mora; Santi Nonell; Michael R Hamblin
Journal:  J Control Release       Date:  2012-07-27       Impact factor: 9.776

5.  Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin.

Authors:  Yu-Tsai Yang; Chin-Tin Chen; Jen-Chang Yang; Tsuimin Tsai
Journal:  AAPS J       Date:  2010-01-26       Impact factor: 4.009

Review 6.  Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxygen Production.

Authors:  Nahid Mehraban; Harold S Freeman
Journal:  Materials (Basel)       Date:  2015-07-20       Impact factor: 3.623

7.  Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.

Authors:  Sanne A M van Lith; Sander M J van Duijnhoven; Anna C Navis; William P J Leenders; Edward Dolk; Jos W H Wennink; Cornelus F van Nostrum; Jan C M van Hest
Journal:  Bioconjug Chem       Date:  2017-01-18       Impact factor: 4.774

8.  EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.

Authors:  Pieter B A A van Driel; Martin C Boonstra; Maxime D Slooter; Raimond Heukers; Marieke A Stammes; Thomas J A Snoeks; Henriette S de Bruijn; Paul J van Diest; Alexander L Vahrmeijer; Paul M P van Bergen En Henegouwen; Cornelis J H van de Velde; Clemens W G M Löwik; Dominic J Robinson; Sabrina Oliveira
Journal:  J Control Release       Date:  2016-03-15       Impact factor: 9.776

Review 9.  Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin.

Authors:  Pragya Pallavi; Karthick Harini; Vijaya Anand Arumugam; Pemula Gowtham; Koyeli Girigoswami; Saradhadevi Muthukrishnan; Agnishwar Girigoswami
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

10.  π-π-Stacked Poly(ε-caprolactone)-b-poly(ethylene glycol) Micelles Loaded with a Photosensitizer for Photodynamic Therapy.

Authors:  Yanna Liu; Marcel H A M Fens; Bo Lou; Nicky C H van Kronenburg; Roel F M Maas-Bakker; Robbert J Kok; Sabrina Oliveira; Wim E Hennink; Cornelus F van Nostrum
Journal:  Pharmaceutics       Date:  2020-04-09       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.